Further studies are needed to investigate the issue
.,BelluzziE,BisagliaM,LazzariniE,TabaresLC,BeltraminiMBubaccoLHuman SOD2 modification by dopamine quinones affects enzymatic activity by promoting its aggregation: Possible implications for Parkinsons disease.2012;7(6):e38026 98
however, recent developments in medical technology, notably in the field of laser treatments, have made the process significantly safer and more effective than it was in the past
Clinical trials show average weight loss of 15-20% of body weight over 68 weeks with semaglutide (Wegovy) and 15-22% with tirzepatide (Zepbound)
10.1016/s0928-4257(01)00040-7 83 Stancic-RokotovD.SlobodnjakZ.AralicaJ.AralicaG.PerovicD.StaresinicM.et al (2001b)
GLP-1s in 2025: Usage, Coverage, and Costs The rise of GLP-1 medications has transformed diabetes and obesity management